Table 4 CAR versus BiTE in MM
From: Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
| Â | Car | BiTE | Bat |
|---|---|---|---|
Advantages | Strong and rapid anti-tumor effects | Off-the-shelf available | Strong and rapid anti-tumor effects |
Efficient in different subgroups | Good anti-tumor control | Potency control | |
Autologous or allogeneic products | Dosing can be stopped in case of adverse effects | Â | |
Disadvantages | Delay in production | Continuous treatment | Delay in production |
Side effects | Costs +  +  | costs (?) | |
costs +  +  +  |  |  |